- Home
- SGN vs BDRX Comparison
SGN vs BDRX Comparison
Compare SGN & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- BDRX
- Stock Information
- Founded
- SGN 2019
- BDRX 2000
- Country
- SGN United States
- BDRX United Kingdom
- Employees
- SGN N/A
- BDRX N/A
- Industry
- SGN
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SGN
- BDRX Health Care
- Exchange
- SGN Nasdaq
- BDRX Nasdaq
- Market Cap
- SGN 2.4M
- BDRX 2.4M
- IPO Year
- SGN 2023
- BDRX N/A
- Fundamental
- Price
- SGN $2.18
- BDRX $3.71
- Analyst Decision
- SGN
- BDRX
- Analyst Count
- SGN 0
- BDRX 0
- Target Price
- SGN N/A
- BDRX N/A
- AVG Volume (30 Days)
- SGN 8.2M
- BDRX 1.2M
- Earning Date
- SGN 03-28-2025
- BDRX 04-21-2025
- Dividend Yield
- SGN N/A
- BDRX N/A
- EPS Growth
- SGN N/A
- BDRX N/A
- EPS
- SGN N/A
- BDRX N/A
- Revenue
- SGN $576,488.00
- BDRX $104,895.00
- Revenue This Year
- SGN N/A
- BDRX N/A
- Revenue Next Year
- SGN N/A
- BDRX N/A
- P/E Ratio
- SGN N/A
- BDRX N/A
- Revenue Growth
- SGN 147.76
- BDRX N/A
- 52 Week Low
- SGN $1.75
- BDRX $3.36
- 52 Week High
- SGN $36.72
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- SGN 42.84
- BDRX 38.74
- Support Level
- SGN $2.04
- BDRX $3.36
- Resistance Level
- SGN $2.49
- BDRX $5.30
- Average True Range (ATR)
- SGN 0.38
- BDRX 0.74
- MACD
- SGN -0.04
- BDRX -0.08
- Stochastic Oscillator
- SGN 8.43
- BDRX 5.99
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.